• Citer

Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24.

par Rose, Angela Mary Catherine;Nicolay, Nathalie;Mazagatos, Clara;Martínez-Baz, Iván;Launay, Odile;De Mot, Laurane ;Bella, Antonino;Lazar, Mihaela;Machado, Ausenda;Kuliešė, Monika;Abela, Stephen;Vučina, Vesna Višekruna;van Gageldonk-Lafeber, Rianne;Bino, Silvia;Dürrwald, Ralf;Paradowska-Stankiewicz, Iwona;Horváth, Judit Krisztina;Duffy, Róisín;Husa, Petr;McMenamin, Jim;Pozo, Francisco;Howard, Jennifer;Latorre-Millán, Miriam;Castilla, Jesús;Nguyen, Liem Binh Luong;Dauby, Nicolas ;Riccardo, Flavia;Ivanciuc, Alina;Gomez, Verónica;Jančorienė, Ligita;Xuereb, Gerd;Petrović, Goranka;Marbus, Sierk;Vasili, Adela;Tolksdorf, Kristin;Bogusz, Joanna;Oroszi, Beatrix;Domegan, Lisa;Součková, Lenka;Marsh, Kimberley;Bacci, Sabrina;Kissling, Esther;I-MOVE & VEBIS Hospital Network teams,
Référence BMC medicine, 23, 1, page (602)
Publication Publié, 2025-11-03

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

The Influenza - Monitoring Vaccine Effectiveness in Europe (I-MOVE/I-MOVE+) and Vaccine Effectiveness, Burden and Impact Studies (VEBIS) hospital networks have conducted seasonal multicentre, test-negative, case-control studies in Europe to measure influenza vaccine effectiveness (IVE) since 2015/16. We measured the effect of chronic conditions on VE of influenza A subtypes among older adults (≥ 65 years) using pooled-season data (2015/16-2023/24).